Emcure Pharma shares at record high! Stock soars 10% today, up 16% in 2 days: More rally ahead? Buy, sell or hold?

Emcure Pharmaceuticals shares hit a record high after rising 16% in two sessions, following strong Q2FY27 results. Profit increased 29% and revenue grew 24%. Jefferies and Kotak retained Buy ratings, citing growth prospects and setting target prices of ₹2,500 and ₹2,450.

Khabar Adda curates headlines like this across Top Stories, Entertainment, Bollywood, Hollywood, Crime and Politics from public RSS feeds. This page links out to livemint.com's own reporting rather than reproducing it — the excerpt above comes from livemint.com's own feed.